Advertisement
Adults are avoiding emergency medical care for fear of catching COVID-19

Fear of COVID-19 Keeping Adults From Emergency Care

0
About 80 percent of poll respondents concerned about contracting COVID-19 from another patient, visitor
The impact of COVID-19 on oncology clinical trials and long-term implications are discussed in a study and recommendations published in JCO Oncology Practice.

Impact of COVID-19 on Oncology Clinical Trials Discussed

0
Recommendations for sustaining cancer care access include permanent expanded support for telehealth
Right ventricular longitudinal strain is a predictor of mortality in patients with COVID-19

RV Strain on Echocardiogram May ID High-Risk COVID-19 Patients

0
Right ventricular longitudinal strain predicts higher mortality in COVID-19
Contact tracing can reduce the time to case isolation of severe acute respiratory syndrome coronavirus 2

Contact Tracing Can Cut Time to Case Isolation in SARS-CoV-2

0
Household contacts had higher risk for infection; children were as likely to be infected as adults
For patients with COVID-19

Anosmia in COVID-19 Linked to Lower Risk for Admission

0
Pulmonary infiltrates and/or pleural effusion on chest radiograph may increase risk for admission
In a cohort of hospitalized adults with COVID-19

Black Patients Overrepresented in Hospitalized COVID-19 Cohort

0
Black patients not more likely to receive invasive mechanical ventilation, die during hospitalization
In 2019

Incidence of Enteric Infections Due to Pathogens Up or Stable

0
Compared with 2016 to 2018, incidence in 2019 was increased for infections caused by five pathogens

April 2020 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for April 2020. This roundup includes the...
The U.S. Food and Drug Administration has granted an emergency use authorization for remdesivir to treat hospitalized patients with suspected or confirmed COVID-19

FDA Issues Emergency Use Authorization for Remdesivir

0
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Cancer patients have an increased case fatality rate from COVID-19

COVID-19 Case Fatality Rate Increased for Cancer Patients

0
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively